Clinical trial
Glucosamine Sulphate and Increased Level of Blood Cholesterol
NCT00251069 · Slidgigtinstituttet, Other · Completed
Key facts
| NCT number | NCT00251069 |
|---|---|
| Title | Glucosamine Sulphate and Increased Level of Blood Cholesterol |
| Official title | Glucosamine Sulphate and Hypercholesterolaemia |
| Lead sponsor | Slidgigtinstituttet, Other |
| Collaborators | Pharma Nord Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Glucosamine sulphate |
| Enrollment | 66 |
| Start date | Apr 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Nov 9, 2005 |
| Last update posted | Nov 9, 2005 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: